Gerresheimer AG [ETR: GXI]
GXI]

The one indisputable factor that plays a crucial role in the pharmaceutical landscape is the packaging. A standard packaging protects the quality of the drugs and maintains its composition at an optimum level. While the packaging is essential for every enterprise irrespective of the type of industry, it becomes a game-changer for the pharma businesses. And companies like Gerresheimer were born to bolster this critical component of the pharma players.

Gerresheimer is the global go-to partner for medicine packaging, drug delivery devices, and solutions with the broadest product range for pharma, health, well-being, and biotech. The company ensures that medicines of all kind are delivered to their final destination safely, reliably, and conveniently. Driven by this ambitious goal, it develops innovative and sustainable solutions that optimises customers’ industrial competence. It was in 1864 was the company was founded by Ferdinand Heye. Since then, Gerresheimer has continuously evolved itself to embrace the latest trends and bring forth innovations that strengthen the pharma realm. Today, as a joint-stock enterprise, it is setting new standards in the packaging diasporas.

As a leading global pharmaceutical primary packaging manufacturer, Gerresheimer offers a comprehensive product portfolio made of glass and plastics in superior quality. The comprehensive suite of solutions includes prefillable syringes, bottles and containers, vials, cartridges, and ampoules. To that end, it even offers standardised and customised packaging for the food and beverage industry as well as nutritional supplements firm. The progressive firm is currently focusing on digitising processes to help customers track and trace solutions.By simply coding and marking primary glass packaging such as injection vials and syringes, Gerresheimer ensures accurate traceability of its solutions and thereby puts counterfeit medicines to rest.

For us, thinking and acting sustainably means taking a long-term view on our impact as a company. Sustainability has thus become an important pillar of our corporate strategy

Besides, it even offers a connected medical device facility that enables clients to directly connect with physician and helps the latter keep a steady track of the patients’ responses. In fact, the company is using the data emanated from these connected devices to shorten the time of clinical trials and enhance the approval of new drugs, thereby adding value in terms of time-to-market.

Innovation forms the core of Gerresheimer. The company is leaving no stone unturned in turning the vision of its customer into reality. Drop Control, Gx® Elite vials, micro pump technology, sterile Gx® RTF glass vials are some of the unprecedented solutions that Gerresheimer has built over time. Produced according to standards, individual specifications, and inspection processes, these products maintain drug integrity at all costs, simplify the process for customers substantially, and reduce potential risks.

With plants based in Europe, North America, South America, and Asia, Gerresheimer has already cemented its position as an eminent partner for the pharma industry worldwide. In addition to moving the curve in the packaging realm, the manufacturing company attaches great importance to the environment. Gerresheimer takes extra care in building sustainable solutions and reducing the carbon footprints, greenhouse gas emissions, and others. To that end, the company has set itself the goal of reducing its Scope 1 and 2 emissions by 50 percent by 2030 (the base year 2019) in absolute terms while at the same time achieving ambitious growth targets. “For us, thinking and acting sustainably means taking a long-term view on our impact as a company. Sustainability has thus become an important pillar of our corporate strategy. It will be an important driver of innovation and growth for us,” concludes Dietmar Siemssen, CEO of Gerresheimer AG.